作者应用精制蝮蛇抗栓酶治疗脑梗死322例,疗效满意,现报告如下。1　临床资料1.1　一般资料　322例均为住院病人,其中男244例,女78例,年龄43～78岁,治疗前进行有关辅助检查,均确诊为脑梗死并且无禁忌症。1.2　疗效评定　按总后勤部卫生部编制的《临床疾病诊断依据治愈好转标准》 The application of purified viper antithrombotic enzyme treatment of cerebral infarction in 322 cases, with satisfactory results, are as follows. 1 Clinical data 1.1 General Information 322 cases were hospitalized patients, including 244 males and 78 females, aged 43 to 78 years, before the treatment of the relevant auxiliary examination, were diagnosed as cerebral infarction and no contraindications. 1.2 Efficacy assessment by the General Logistics Department prepared by the Ministry of Health, “clinical diagnosis of disease based on improvement criteria for cure”